OmniActive Health Technologies has released a new survey, offering insights the company considers essential for guiding the development of future health products that align with evolving consumer needs.

Research in women’s health, mental health, sleep and longevity has long been underfunded despite growing demand for innovation in these vital areas. Susanne Mitschke, co-founder of contract research organization Citruslabs, believes that robust clinical trials are essential to closing this gap.

Phil Vigeant, CEO and cofounder of PlantFusion, says active consumers should consider plant protein.

While women have been historically underserved, the last decade has witnessed a rise in products dedicated to improving women’s health—tackling issues such as fertility, pregnancy, menstruation, menopause, pelvic health, sexual wellness and more.

McKinsey’s ‘Future of Wellness’ report found that nearly one in five consumers and one in three millennials in the U.S. prefer personalized wellness solutions. Pelin Thorogood of Radicle Science says that today, more than ever, advanced technologies like AI are accelerating a seismic shift toward personalization.

Consumer surveys have informed market research since the late 1800s, but traditional methods only scratch the surface—prompting one company to push behavioral research boundaries by accessing the subconscious drivers of ingredient preferences.

Los Angeles-based Axiom Foods recently debuted Oryzatein 2.0, the first patented plant protein with no detectable levels of lead, according to independent lab tests.

The dietary supplement industry relies heavily on other regions for ingredients. With today’s ever-changing geopolitical climate, Craig Koffler, VP of sales at the Freemen Nutra Group says that diversifying the supply chain is no longer optional — it’s essential.

The CEO discusses the rapid evolution of the essential oils market over the past decade and doTERRA’s role in driving this growth and innovation.

Without any marketing, Chiyo became the top Google search result for postpartum nutrition, attracting thousands of pre-orders and recognition from The New York Times and Bon Appétit. The company has since expanded beyond postpartum care to address various women’s health concerns including fertility, PCOS and endometriosis.